Latest Headlines

  1. Novartis Expands U.S. footprint With New Radioligand Therapy Facility In California 11/12/2025

    Novartis, a leading global innovative medicines company, today announced the opening of a new 10,000-square-foot radioligand therapy (RLT) manufacturing facility in Carlsbad, California. This state-of-the-art site represents a key milestone in the company’s previously announced $23 billion investment in US infrastructure over the next five years.

  2. AES Cleanroom Technology Establishes New Office In Research Triangle Park To Support Regional Drug Manufacturing Growth 11/11/2025

    AES Cleanroom Technology, an award-winning leader in modular cleanroom design and construction, has opened a new regional office in Research Triangle Park (RTP), reinforcing its commitment to serving the Southeast’s fast-growing life sciences, biotechnology, and advanced manufacturing sectors.

  3. Federal Equipment Announces Diagnostics Laboratory Equipment Auction 11/10/2025

    Federal Equipment held in conjunction with Proxio Group announces diagnostics laboratory equipment auction.

  4. How Eli Lilly's New Netherlands Drug Manufacturing Facility Strengthens Global Oral Solid Dose Supply Chains 11/3/2025
  5. CDMO Codis Launches As Commercial Spray Drying And Amorphous Solid Dispersions Provider 10/31/2025

    Codis officially launches as a new global CDMO specializing in commercial-scale spray drying, amorphous solid dispersions (ASD), and particle engineering technologies. Formed through the integration of Particle Dynamics in the US and the Haverhill, UK spray drying facility previously operated by EUROAPI, Codis combines decades of regulatory expertise and manufacturing strength under one brand.

  6. Eli Lilly Announces $1.2 Billion Investment To Expand Puerto Rico Manufacturing Site For Next-Gen Oral Medicines 10/30/2025

    Eli Lilly and Company (NYSE: LLY) announced today a planned investment of more than $1.2 billion to expand and modernize its Lilly del Caribe manufacturing site in Carolina, Puerto Rico. This new investment will integrate advanced technologies and expand production capacity within the existing campus to support the company's growing portfolio of oral solid medicines in cardiometabolic health, neuroscience, oncology and immunology.

  7. Apeloa Successfully Passes 20th FDA Inspection With No Action Indicated 10/30/2025

    Following a rigorous and comprehensive evaluation process, Apeloa Pharmaceutical has successfully passed its 20th US FDA inspection, a top achievement in the industry that underscores Apeloa’s exemplary quality and management standards.

  8. Tema Sinergie Acquires Majority Stake In Aseptic Filling OEM 6Bio 10/29/2025

    TEMA Sinergie S.p.A., a global leader in isolation systems for the Radiopharma and Biotech Pharma industries, today announced the acquisition of a majority stake in 6Bio, a Spanish company specialized in high-performance aseptic filling technology.

  9. Serán Bioscience Expands Commercial Manufacturing With New 100,000 Sq. Ft. Campus In Bend, Oregon 10/29/2025

    Serán BioScience, LLC, a leading science-driven drug development partner, today announced the completion of two of the three new buildings and commencement of construction of the third facility for of its new 100,000 ft2 commercial manufacturing campus in Bend, Oregon. The new campus will encompass a 50,000 ft2 manufacturing facility, complemented by an adjacent 50,000 ft2 space dedicated to specialized packaging and supply chain operations. The expansion marks a significant milestone in Serán’s mission to provide fully integrated support from first-in-human (FiH) trials through commercial-scale production of small-molecule therapeutics.

  10. Owen Mumford Launches EcoSafe® Safety Syringe Platform – Smarter For Budgets And Kinder To The Planet 10/29/2025

    Oxford - Medical device expert Owen Mumford has extended its 1ml safety syringe platform by adding a companion reusable autoinjector.